Seshu Tyagarajan

Insider Reports History

Entity
Individual
Location
Candel Therapeutics, Inc., 117 Kendrick St Suite 450, Needham, MA
Signature
/s/ Charles Schoch, as Attorney-in-Fact for Seshu Tyagarajan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Seshu Tyagarajan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Chief Technology Officer Common Stock 126K $572K $4.56 Nov 29, 2024 Direct

Insider Reports Filed by Seshu Tyagarajan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CADL Candel Therapeutics, Inc. Nov 29, 2024 1 -$92.9K 4 Dec 3, 2024 Chief Technology Officer
CADL Candel Therapeutics, Inc. Jul 17, 2024 1 -$96.1K 4 Jul 19, 2024 Chief Technology Officer
CADL Candel Therapeutics, Inc. Jul 11, 2024 1 -$79.6K 4 Jul 15, 2024 Chief Technology Officer
CADL Candel Therapeutics, Inc. Nov 28, 2023 1 -$15.6K 4 Nov 30, 2023 Chief Technology Officer
CADL Candel Therapeutics, Inc. Nov 26, 2023 1 $0 4 Nov 28, 2023 Chief Technology Officer
CADL Candel Therapeutics, Inc. Apr 28, 2023 1 $0 4 May 2, 2023 Chief Technology Officer
CADL Candel Therapeutics, Inc. Dec 8, 2022 2 $25.1K 4 Dec 12, 2022 Chief Technology Officer
CADL Candel Therapeutics, Inc. Nov 28, 2022 1 $0 4 Nov 30, 2022 Exhibit 24 - Power of Attorney. Officer Title: Chief Technical and Development Officer
CADL Candel Therapeutics, Inc. Apr 14, 2022 1 $0 4 Apr 15, 2022 Chief Technical and Development Officer
CADL Candel Therapeutics, Inc. Apr 14, 2022 0 $0 3 Apr 15, 2022 Chief Technical and Development Officer Exhibit 24 - Power of Attorney